Lynwood Capital Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-313
Closed -$55.6K 81
2023
Q4
$55.6K Buy
+313
New +$55.6K 0.24% 28